This document outlines CARE Bangladesh’s five years of experience in working with drug users to prevent HIV, gained through their DFID funded HIV Programme.
There is a rising trend of HIV prevalence among injecting drug users in Bangladesh and in one area of Dhaka city. The reported rate of HIV prevalence is 8.9%, indicating the start of a concentrated epidemic among this group.
To contain the spread of the disease, the project used a harm reduction approach, including services such as peer education, abcess and STD treatment, condom distribution and needle-syringe exchange.
The document also describes the challenges faced during the implementation of the project and the lessons learned.
Drug users at risk to HIV: Documenting our experience 2000 - 2004
- Published: June 2006
Themes:
Related Publications
Latin America and the Caribbean rapid gender analysis for COVID-19
Women and girls across Latin America and the Caribbean (LAC) are facing a terrifying mix of increased domestic violence and care burden, as well as a lower access to income and jobs, and potential social unrest as a result of the coronavirus... Read more...
Global Rapid Gender Analysis for COVID-19
This Rapid Gender Analysis of the COVID-19 pandemic, based on secondary data analysis undertaken between 12-20 March 2020, explores the current and potential gendered dimensions of COVID-19 and highlights the ways in which women, girls and other... Read more...
Gender implications of COVID-19 outbreaks in development and humanitarian settings
This paper, based on lessons learned and analysis of prior public health crises in the developing world and humanitarian settings, aims to help ensure COVID-19 mitigation and response efforts take gender into account in appropriate and meaningful... Read more...
Improving maternal and child health in Asia through innovative partnerships and approaches: The case of Bangladesh
This research brief is part of a series capturing the impact of project interventions and analysing and documenting CARE’s best practices under the GSK ‘20% Reinvestment Initiative’ in Asia. This briefing focuses on the case of... Read more...
Improving maternal and child health in Asia through innovative partnerships and approaches: The case of Afghanistan
This research brief is part of a series capturing the impact of project interventions and analysing and documenting CARE’s best practices under the GSK ‘20% Reinvestment Initiative’ in Asia. This briefing focuses on the case of... Read more...
Improving maternal and child health in Asia through innovative partnerships and approaches
This research brief provides an overview of the impact of project interventions and CARE’s best practices under the GSK ‘20% Reinvestment Initiative’ in Asia. This strategic partnership between CARE and GSK focuses on improving maternal and... Read more...
Improving maternal and child health in Asia through innovative partnerships and approaches: The case of Nepal
This research brief is part of a series capturing the impact of project interventions and analysing and documenting CARE’s best practices under the GSK ‘20% Reinvestment Initiative’ in Asia. This briefing focuses on the case of... Read more...
